TITLE

Continuing Clinical Responsibility

AUTHOR(S)
Harvey, Peter
PUB. DATE
October 1974
SOURCE
British Medical Journal;10/5/1974, Vol. 4 Issue 5935, p49
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64111963

 

Related Articles

  • American Society for Clinical Research. Ibsen, Robert L. // Quintessence International;Aug1991, Vol. 22 Issue 8, p601 

    A letter to the editor regarding the responsibility of the American Society for Clinical Research to sponsor continuing education in the field of dentistry is presented.

  • An Evaluation of Continuity Clinic Redesign. Wieland, Mark L.; Halvorsen, Andrew J.; Chaudhry, Rajeev; Reed, Darcy A.; McDonald, Furman S.; Thomas, Kris G. // JGIM: Journal of General Internal Medicine;Dec2013, Vol. 28 Issue 12, p1557 

    A response from the authors of an article about residency continuity clinic in the previous issue is presented.

  • Clinical Utility of Continuing Trastuzumab Beyond Brain Progression in HER-2-Positive Metastatic Breast Cancer. Metro, Giulio; Sperduti, Isabella; Russillo, Michaelangelo; Milella, Michele; Cognetti, Francesco; Fabi, Alessandra // Oncologist;Dec2007, Vol. 12 Issue 12, p1467 

    A letter to the editor is presented in response to an article about the clinical utility of continuing trastuzumab beyond brain progression in HER-2-Positive Metastatic Breast Cancer.

  • In Reply. Gori, Stefania; De Angelis, Verena; Colozza, Mariantonietta; Crinò, Lucio // Oncologist;Dec2007, Vol. 12 Issue 12, p1469 

    A response to a letter to the editor about the article on the clinical utility of continuing trastuzumab beyond progression in HER-2-positive metastatic breast cancer (MBC) patients is presented.

  • Delayed Hypersensitivity and Cell-Mediated Immunity. Maddison, Shirley E. // Clinical Pediatrics;Sep1973, Vol. 12 Issue 9, p529 

    The field of delayed hypersensitivity continues to grow in complexity. One expects that increasing understanding of cell-mediated responses in clinical immunology will lead to greater advances in this field. This review explains and summarizes the pertinent newer concepts of clinical promise.

  • Look Before You Leap: Conducting Clinical Studies. Seymour, Patricia; Kerwin, Maria // Review of Ophthalmology;Jun2003, Vol. 10 Issue 6, p28 

    Discusses the need to understand the organizational, financial and personnel-related challenges of conducting clinical research studies in the field of ophthalmology in the United States. Regulatory responsibilities; Clinical issues; Audits and continuing education. INSET: Getting Involved...

  • Response to Ketamine Article. Pirrello, Rosene D. // Journal of Palliative Medicine;Jul2012, Vol. 15 Issue 7, p734 

    A letter to the editor is presented in response to the article, "Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care," by S Salas and colleagues, in the May 2012 issue.

  • CNE/CME QUESTIONS.  // ED Management;Jun2013, Vol. 26 Issue 6, p71 

    A quiz concerning continuing medical education questions regarding the responsibilities of the clinical team leader (CTL), hardest changes to implement in the emergency department (ED) at the Truman Medical Center Lakewood, and the key to the hospital's success for stroke patients.

  • Impact of published clinical outcomes data: case study in NHS hospital trusts. Mannion, Russell; Goddard, Maria // BMJ: British Medical Journal (International Edition);8/4/2001, Vol. 323 Issue 7307, p260 

    Conclusions: Those responsible for developing clinical indicator programmes should develop robust datasets. They should also encourage a working environment and incentives such that these data are used to improve continuously.

  • Is Extended or Continuous Infusion of Carbapenems the Obvious Solution to Improve Clinical Outcomes and Reduce Mortality? Frippiat, Frédéric; Vercheval, Christelle; Lambermont, Bernard; Damas, Pierre // Clinical Infectious Diseases;Jul2013, Vol. 57 Issue 2, p324 

    A letter to the editor is presented in response to the article "Clinical Outcomes with Extended or Continuous Versus Short-Term Intravenous Infusion of Carbapenems and Piperacillin/ Tazobactam: A Systematic Review and Metaanalysis" by M E Falagas and coworkers in the 2013 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics